Managing the Bipolar Depressive Spectrum: How Wide is the Spectrum?

Strategies to managing the bipolar depressive spectrum.
Roger McIntyre, MD, FRCPC
Format: Microsoft PowerPoint (.ppt)
File Size: 1.46 MB
Released: August 31, 2021

Information on this Educational Activity

Faculty

Roger McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
Department of Psychiatry/Pharmacology
University of Toronto
Head, Mood Disorders Psychopharmacology Unit
Department of Psychiatry
Toronto, Canada

Roger McIntyre, MD, FRCPC, has disclosed that he has received consulting fees from AbbVie, Allergan, Eisai, Intra-Cellular, Janssen, Lundbeck, Minerva, Neurocrine, Otsuka, Pfizer, Purdue, Sunovion, and Takeda and serves as CEO of AltMed.

Program Medium

This program has been made available online.

Acknowledgements

This activity is provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants provided by
AbbVie
Intra-Cellular Therapies
Neurocrine Biosciences
Sunovion

Related Content

Clinical Care Options (CCO) commentary by Thomas L. Schwartz, MD, on choosing the right atypical antipsychotic in bipolar I and bipolar II patients

Thomas L. Schwartz, MD Released: October 15, 2021

Attention deficits in a bipolar patient with a history of cannabis use from Clinical Care Options (CCO)

Joseph F. Goldberg, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I (Preapproved) credit Released: October 7, 2021 Expired: October 6, 2022

Slides from a presentation that educates clinicians on advances in the treatment of tardive dyskinesia (TD)

John M. Kane, MD Released: October 1, 2021

In Neuroscience Research Review (GME Research Review), Dr Gupta provides commentary on the latest research relevant to clinical practice for opioid use disorder, emotional exhaustion & burnout, PTSD among veterans and familiar risk of depression.

Released: September 29, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue